Differences in Vitreous Protein Profiles in Patients With Proliferative Diabetic Retinopathy Before and After Ranibizumab Treatment

Proliferative diabetic retinopathy (PDR) accounts for severe impact on vision, its mechanism is still poorly understood. To compare the differences of vitreous protein profiles in PDR patients before and after a complete anti-vascular endothelial growth factor (VEGF) loading dose with ranibizumab tr...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Xinping She, Chen Zou, Zhi Zheng
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-05-01
coleção:	Frontiers in Medicine
Assuntos:	proliferative diabetic retinopathy proteomics ranibizumab label-free LC-MS/MS PRM
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fmed.2022.776855/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!